Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote  - 12/06
31.2 CNY   -1.11%
 SummaryQuotesChartsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/30/2016 12/01/2016 12/02/2016 12/05/2016 12/06/2016 Date
32.33(c) 32.66(c) 32.26(c) 31.55(c) 31.2 Last
33 115 45 381 31 646 34 200 29 142 Volume
0.00% +1.02% -1.22% -2.20% -1.11% Change
More quotes
Financials ( CNY)
Sales 2016 1 959 M
EBIT 2016 495 M
Net income 2016 475 M
Finance 2016 752 M
Yield 2016 1,51%
Sales 2017 2 191 M
EBIT 2017 633 M
Net income 2017 558 M
Finance 2017 1 048 M
Yield 2017 1,77%
P/E ratio 2016 19,94
P/E ratio 2017 16,96
EV / Sales2016 4,45x
EV / Sales2017 3,84x
Capitalization 9 465 M
More Financials
Company
Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products.Its products include water-soluble, botanical medicine, penicillin injection, antibiotics and others.The company was founded in 1969 and is headquartered in Nanchang, China. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news : Pharmaceuticals - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Pharmaceuticals - NEC
Advertisement
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Technical analysis trends JIANGZHONG PHARMA...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 44,6  CNY
Spread / Average Target 41%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hong Guang Zhong Chairman & General Manager
Qi Yu Chairman-Supervisory Board
Juan Luo Chief Financial Officer
Min Zhi Yi Director
Lixin Liu Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JIANGZHONG PHARMACEUTI..-10.60%1 377
JOHNSON & JOHNSON8.98%304 536
PFIZER INC.-2.14%191 699
ROCHE HOLDING LTD.-19.65%189 885
NOVARTIS AG-20.79%180 598
MERCK & CO., INC.15.73%166 118
More Results